21St Century Oncology Holdings, Inc. (RTSX) SEC Filing 10-Q Quarterly report for the period ending Wednesday, September 30, 2015

Earnings Press Release
10-Q Quarterly Report
10-Q QoQ Changes
21St Century Oncology Holdings, Inc.
Ticker: RTSX CIK: 1503518

Exhibit 99.1

21ST CENTURY ONCOLOGY HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)
(unaudited)
		PRELIMINARY			ADJUSTMENTS				FINAL
		September 30,			September 30,				September 30,
		2015			2015				2015

ASSETS
	Current assets:
	Cash and cash equivalents	$	47,793		$	—			$	47,793
	Restricted cash	80			—				80
	Marketable securities	622			—				622
	Accounts receivable, net	149,224			—				149,224
	Prepaid expenses	9,381			—				9,381
	Inventories	5,162			—				5,162
	Deferred income taxes	191			—				191
	Other	8,056			—				8,056
	Total current assets	220,509			—				220,509

	Equity investments in joint ventures	1,236			—				1,236
	Property and equipment, net	249,392			—				249,392
	Real estate subject to finance obligation	11,625			—				11,625
	Goodwill	492,084			—				492,084
	Intangible assets, net	74,434			—				74,434
	Other assets	49,282			—				49,282
	Total assets	$	1,098,562		$	—			$	1,098,562

LIABILITIES AND EQUITY

	Current liabilities:
	Accounts payable	$	59,397		$	—			$	59,397
	Accrued expenses	111,084			28,977			A	140,061
	Income taxes payable	1,814			—				1,814
	Current portion of long-term debt	30,858			—				30,858
	Current portion of finance obligation	481			—				481
	Other current liabilities	6,484			—				6,484
	Total current liabilities	210,118			28,977				239,095
	Long-term debt, less current portion	1,009,196			—				1,009,196
	Finance obligation, less current portion	12,057			—				12,057
	Embedded derivative & other financial instrument features of Series A convertible redeemable preferred stock	23,541			3,798			B	27,339
	Other long-term liabilities	39,861			—				39,861
	Deferred income taxes	3,716			—				3,716
	Total liabilities	1,298,489			32,775				1,331,264

	Series A convertible redeemable preferred stock, $0.001 par value, $1,000 stated value, 3,500,000 authorized, 385,000 issued and outstanding at September 30, 2015 and December 31, 2014	404,179			(33,701		)	C	370,478
	Noncontrolling interests - redeemable	19,934			—				19,934

	Commitments and Contingencies

	Equity:
	Common stock, $0.01 par value, 1,000,000 shares authorized 1,059 and 1,028 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	—			—				—
	Additional paid-in capital	569,036			30,697			D	599,733
	Retained deficit	(1,174,400		)	(29,771		)	E	(1,204,171		)
	Accumulated other comprehensive loss, net of tax	(45,008		)	—				(45,008		)
	Total 21st Century Oncology Holdings, Inc. shareholder’s deficit	(650,372		)	926				(649,446		)
	Noncontrolling interests - nonredeemable	26,332			—				26,332
	Total deficit	(624,040		)	926				(623,114		)
	Total liabilities and equity	$	1,098,562		$	—			$	1,098,562

The following information was filed by 21St Century Oncology Holdings, Inc. (RTSX) on Friday, February 12, 2016 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate 21St Century Oncology Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by 21St Century Oncology Holdings, Inc..

Continue

Please wait while we load the requested 10-Q report or click the link below:

https://last10k.com/sec-filings/report/1503518/000110465916096509/a15-18065_110q.htm